How stability studies in sterile injectables support quality across the product lifecycle

How do stability studies support the quality, safety, and efficacy of sterile injectable drug products throughout their entire lifecycle? In this video, our expert Jörg explains the critical role of stability testing in pharmaceutical development — from early formulation screening and clinical development to regulatory approval and commercial product monitoring. Discover why stability studies are essential for: ✅ Patient safety and product efficacy ✅ Global storage and distribution requirements ✅ Regulatory compliance and market approval ✅ Shelf-life determination and lifecycle management ✅ Assessing degradation risks and critical quality attributes The video also provides an overview of key stability study approaches, including real-time, accelerated, and intermediate studies, and highlights how advanced analytical techniques such as LC-MS (Liquid Chromatography–Mass Spectrometry) support the evaluation of product stability. Whether you're involved in pharmaceutical development, manufacturing, quality assurance, or regulatory affairs, this video offers valuable insights into the scientific foundation behind stable, reliable, and compliant sterile injectable products. -------------------------------------------------------------------------------------------------- Get more information on: Our website: https://www.vetter-pharma.com/en/serv... LinkedIn: https://www. linkedin.com/company/vetter-pharma or subscribe to our newsletter: https://www.vetter-pharma.com/en/news... -------------------------------------------------------------------------------------------------- Click here to subscribe to our YouTube channel:    / @vetterpharmaservices   -------------------------------------------------------------------------------------------------- Disclaimer: This motion picture, in whole or in part, including layouts, logos, software, text, illustrations, and graphics are protected by copyright law, with all rights reserved. This motion picture and its contents may not be reproduced, adapted, modified, transmitted, distributed or used without the prior and written consent of Vetter. The information contained in this motion picture is for general information purposes only. Vetter makes no representations, warranties, or assurances of any kind, neither expressed nor implied, about the completeness, accuracy, reliability, suitability, or availability with respect to this motion picture or the information, products, services, systems or related graphics contained within. Vetter Pharma International GmbH Eywiesenstr. 88212 Ravensburg Germany Vetter Pharma International USA Inc. 4901 Searle Parkway, Suite 300A Skokie, IL 60077 USA